1.WHO. Weekly epidemiological record. No. 16, 76, pp. 117–124. Geneva: World Health Organization, 2001.
2.Gaffga, NH, et al. Cholera: a new homeland in Asia. American Journal of Tropical Medicine and Hygiene 2007; 77: 705–713.
3.WHO. Cholera summary for 2006. Weekly Epidemiological Record 2007; 31: 273–284.
4.Barua, D. History of cholera. In: Barua, D, Greenough, WB III, eds. Cholera. New York, London: Plenum Medical Book Company, 1992, pp. 1–36.
5.Sakazaki, R. Bacteriology of V. cholerae and related organism. In: Barua, D, Greenough, WB III, eds. Cholera. New York, London: Plenum Medical Book Company, 1992, pp. 37–55.
6.The Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. Large epidemic of cholera like disease in Bangladesh caused by Vibrio cholerae non-O1. Lancet 1993; 342: 387–390.
7.Siddique, AK, et al. Emergence of a new epidemic strain of Vibrio cholerae in Bangladesh: an epidemiological study. Tropical and Geographical Medicine 1994; 46: 147–150.
8.Nair, GB, et al. Spread of Vibrio cholerae O139 Bengal in India. Journal of Infectious Diseases 1994; 169: 1029–1034.
9.Woodward, WE, Mosley, WH. The spectrum of cholera in rural Bangladesh – comparison of El Tor Ogawa and Classical Inaba infection. American Journal of Epidemiology 1972; 96: 342–351.
10.Chandu, MG. The seventh cholera pandemic. WHO Chronicle 1971; 25: 155–160.
11.Sack, RB, et al. A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. Journal of Infectious Diseases 2003; 187: 96–101.
12.WHO. Guidelines for cholera control. WHO/CDD/SER.90.4 Rev. 4, 1992.
13.Siddique, AK, et al. Cholera epidemics in Bangladesh: 1985–1991. Journal of Diarrhoeal Disease Research 1992; 10: 79–86.
14.WHO. Programme for control of diarrhoeal disease (CDD/83.3 Rev. I). In: Manual for Laboratory Investigators of Acute Enteric Infections. 1987 Geneva: World Health Organization.
15.Svennerholm, A-M, Holmgren, J. Identification of Escherichia coli heat – labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure. Current Microbiology 1978; 1: 19–23.
16.Iwanaga, M, et al. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiology and Immunology 1986; 30: 1075–1083.
17.Svennerholm, A-M, et al. Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Medical Biology 1986; 64: 23–30.
18.Nair, GB, et al. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalised patients with acute diarrhoea in Bangladesh. Journal of Clinical Microbiology 2002; 40: 3296–3299.
19.Faruque, SM, et al. Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strain carrying classical CTX prophage. Proceedings of the National Academy of Sciences USA 2007; 104: 5151–5156.
20.Nair, GB, et al. Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. Journal of Clinical Microbiology 2006; 44: 4211–4213.
21.Siddique, AK, Akram, K, Islam, Q. Why cholera still takes lives in rural Bangladesh? Tropical Doctor 1988; 18: 40–42.
22.Siddique, AK, et al. Why treatment failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire. Lancet 1995; 345: 359–361.
23.Sack, DA, Sack, RB, Chaignat, CL. Getting serious about cholera. New England Journal of Medicine 2006; 355: 649–651.